You are here : Home / Annual Results / DR REDDYS LABORATORIES LTD

DR REDDYS LABORATORIES Financial Statement Analysis [BOM: 500124|NSE : DRREDDY]

The Revenues of DR REDDYS LABORATORIES have increased by 8.74% YoY.
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -3.79 % YoY.
Y-o-Y REVENUES OPERATING MARGIN PROFIT AFTER TAX EPS ROCE Details👇

DR REDDYS LABORATORIES Share Price vs Sensex

Current Share Price : ₹4,362.4
Current MarketCap: ₹ 72,589.5 Cr
Updated EOD on :Jan 24,2022

Share Price Returns(%) 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES

-7%

-6%

-13.6%

SENSEX

-6.2%

0.3%

18.4%

Smart-Investing
What is the Intrinsic Value of DR REDDYS LABORATORIES ?

DR REDDYS LABORATORIES Last 5 Annual Financial Results
[BOM: 500124|NSE : DRREDDY]

ConsolidatedMar2021
Mar2020
Mar2019
Mar2018
Mar2017
Revenues ₹19,048 Cr₹17,517 Cr₹15,448 Cr₹14,281 Cr₹14,196 Cr
Expenses ₹15,178 Cr₹15,047 Cr₹12,270 Cr₹11,930 Cr₹11,724 Cr
Operating Profit (Excl OI) ₹3,870 Cr₹2,470 Cr₹3,178 Cr₹2,351 Cr₹2,472 Cr
Other Income ₹291 Cr₹621 Cr₹338 Cr₹155 Cr₹172 Cr
Interest ₹97 Cr₹98 Cr₹89 Cr₹79 Cr₹63 Cr
Depreciation ₹1,229 Cr₹1,163 Cr₹1,135 Cr₹1,077 Cr₹1,027 Cr
Profit Before Tax ₹2,836 Cr₹1,830 Cr₹2,292 Cr₹1,350 Cr₹1,554 Cr
Profit After Tax ₹1,904 Cr₹1,970 Cr₹1,906 Cr₹912 Cr₹1,257 Cr
Consolidated Net Profit ₹1,952 Cr₹2,026 Cr₹1,950 Cr₹947 Cr₹1,292 Cr
Earnings Per Share (Rs)₹117.28₹121.90₹117.47₹57.04₹77.93
PAT Margin (%)9.9911.2512.346.398.86
ROE(%)11.5313.3814.427.4010.20
ROCE(%)15.2410.8113.418.219.77
Total Debt/Equity(x)0.170.140.280.410.40
Key Financials
Market Cap : ₹ 72,589.5 Cr
Revenue (TTM) : ₹ 20,442.1 Cr
Net Profit(TTM) : ₹ 1,887.1 Cr
EPS (TTM) : ₹ 113.4
P/E (TTM) : 38.5

Check out Industry Peers

Peers & Returns1W1M1Y
DR REDDYS LABORATORIES -7% -6% -13.6%
SUN PHARMACEUTICAL INDUSTRIES -5.4% 1.9% 35.7%
DIVIS LABORATORIES -10.7% -9.1% 14.7%
CIPLA -1.2% -1.8% 5.4%
GLAND PHARMA -10.1% -15.1% 56%
PIRAMAL ENTERPRISES -8% -8.2% 58.9%
CADILA HEALTHCARE -6% -12.5% -15.5%
TORRENT PHARMACEUTICALS -2.5% 2% 14.9%
ALKEM LABORATORIES 0.3% 1.1% 16.4%

What is the Fundamental Analysis of DR REDDYS LABORATORIES ?

DR REDDYS LABORATORIES Revenues
[BOM: 500124|NSE : DRREDDY]

Revenues
Y-o-Y

8.74 %

5 Yr CAGR

7.63 %

Years Revenues % Change
Mar2021 ₹19,048 Cr
8.74
Mar2020 ₹17,517 Cr
13.39
Mar2019 ₹15,448 Cr
8.17
Mar2018 ₹14,281 Cr
0.60
Mar2017 ₹14,196 Cr -
What is the Valuation of DR REDDYS LABORATORIES ?

DR REDDYS LABORATORIES Operating Profit
[BOM: 500124|NSE : DRREDDY]

Operating Profit
Y-o-Y

56.65 %

5 Yr CAGR

11.85 %

Years Operating Profit % Change
Mar2021 ₹3,870 Cr
56.65
Mar2020 ₹2,470 Cr
-22.27
Mar2019 ₹3,178 Cr
35.17
Mar2018 ₹2,351 Cr
-4.89
Mar2017 ₹2,472 Cr -
Operating Margins
Y-o-Y

44.11 %

5 Yr CAGR

3.94 %

Years Operating Margin% % Change
Mar2021 20.32%
44.11
Mar2020 14.1%
-31.45
Mar2019 20.57%
24.97
Mar2018 16.46%
-5.46
Mar2017 17.41% -

DR REDDYS LABORATORIES Profit After Tax
[BOM: 500124|NSE : DRREDDY]

Profit After Tax(PAT)
Y-o-Y

-3.67 %

5 Yr CAGR

10.86 %

Years Profit After Tax % Change
Mar2021 ₹1,952 Cr
-3.67
Mar2020 ₹2,026 Cr
3.90
Mar2019 ₹1,950 Cr
105.96
Mar2018 ₹947 Cr
-26.72
Mar2017 ₹1,292 Cr -
PAT Margins
Y-o-Y

-11.20 %

5 Yr CAGR

3.05 %

Years PAT Margin(%) % Change
Mar2021 9.99 %
-11.20
Mar2020 11.25 %
-8.83
Mar2019 12.34 %
93.11
Mar2018 6.39 %
-27.88
Mar2017 8.86 % -

DR REDDYS LABORATORIES Earnings Per Share (EPS)
[BOM: 500124|NSE : DRREDDY]

EPS
Y-o-Y

-3.79 %

5 Yr CAGR

10.76 %

Years EPS % Change
Mar2021 ₹117
-3.79
Mar2020 ₹122
3.77
Mar2019 ₹117
105.94
Mar2018 ₹57
-26.81
Mar2017 ₹78 -

DR REDDYS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500124|NSE : DRREDDY]

ROCE
Y-o-Y

40.98 %

5 Yr CAGR

11.76 %

Years ROCE % Change
Mar2021 15.24%
40.98
Mar2020 10.81%
-19.39
Mar2019 13.41%
63.34
Mar2018 8.21%
-15.97
Mar2017 9.77% -
What is the Valuation of DR REDDYS LABORATORIES ?
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

DR REDDYS LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE DIVIDEND STABILITY -5% 2.5% 19.9%
S&P BSE 100 ESG INDEX -6.2% 0.6% 22.8%
S&P BSE SENSEX -6.2% 0.3% 18.4%
S&P BSE CARBONEX -6.3% 0.3% 20.4%
S&P BSE LARGECAP -6.3% 0.3% 20.7%
S&P BSE SENSEX50 -6.3% 0.4% 20.2%
S&P BSE 100 LARGECAP TMC -6.4% -0.1% 20.8%
S&P BSE 100 -6.5% 0.1% 20.7%
S&P BSE LARGE MIDCAP -6.6% -0.2% 21.9%
S&P BSE 200 -6.6% -0.2% 22.6%
S&P BSE 250 LARGEMIDCAP -6.6% -0.3% 23.3%
MFG -6.7% -0.4% 18.9%
S&P BSE 500 -6.8% -0.2% 24.9%
S&P BSE ALLCAP -6.8% -0.1% 26.1%
S&P BSE HEALTHCARE -6.8% -5.1% 10.7%
S&P BSE GREENEX -6.9% 2.3% 26.8%
NSE Indices1W1M1Y
NIFTY GROWTH SECTOR 15 -2.6% 2% 7.2%
NIFTY100 LOW VOLATILITY 30 -5.4% -0.7% 15.8%
NIFTY PHARMA -6.2% -4.7% 2.7%
NIFTY 50 -6.3% 0.5% 20.1%
NIFTY 100 -6.4% -0% 20.6%
NIFTY50 EQUAL WEIGHT -6.4% 0.6% 26.6%
NIFTY 100 EQUAL WEIGHT -6.6% -1.1% 25%
NIFTY 200 -6.7% -0.3% 22.5%
NIFTY HEALTHCARE -6.7% -5.2% NA
NIFTY 500 -6.8% -0.3% 24.9%
NIFTY LARGE MIDCAP 250 -7.1% -1% 28.9%
NIFTY500 MULTICAP 50:25:25 -7.2% -0.3% 33%

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


How the annual revenues of DR REDDYS LABORATORIES have changed ?

The Revenues of DR REDDYS LABORATORIES have increased by 8.74% YoY .

How the Earnings per Share (EPS) of DR REDDYS LABORATORIES have changed?

The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has decreased by -3.79 % YoY .

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD
Quarterly Results of PIRAMAL ENTERPRISES LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of ALKEM LABORATORIES LTD
Quarterly Results of LUPIN LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of ABBOTT INDIA LTD
Quarterly Results of LAURUS LABS LTD
Quarterly Results of IPCA LABORATORIES LTD

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z